Oncology

AALL1331 (intermediate- and high-risk relapse)

Study

AALL1331 (low-risk relapse)

Study

AALL1731

Study

Acid phosphatase, increased

Finding

ACOSOG Z0011 (10-year survival)

Study

ACOSOG Z0011 (5-year survival)

Study

Actinic keratosis

Disease

Acute lymphoblastic leukemia

Disease

Acute myeloid leukemia

Disease

Acute promyelocytic leukemia

Disease

ADAURA

Study

ADIGE

Study

Adjuvant HAIC with FOLFOX for HCC

Study

Adrenal incidentaloma

Disease

Adrenocortical carcinoma

Disease

ADRIATIC

Study

AEGEAN

Study

Age Trial

Study

AHA STEROID

Study

Aldolase, increased

Finding

Alemtuzumab

Drug

ALEX

Study

ALEXANDRA/IMpassion030

Study

ALLEGRO

Study

Alliance A011502

Study

Allopurinol

Drug

Alpha-fetoprotein, increased

Finding

AMBASSADOR

Study

AMPLIFY (acalabrutinib/venetoclax)

Study

AMPLIFY (acalabrutinib/venetoclax/obinutuzumab)

Study

Ampullary cancer

Disease

ANAHYDRET

Study

Anal cancer

Disease

Anastrozole

Drug

ANCHOR

Study

ANTICIPUSC

Study

Antimicrobial prophylaxis in pancreatoduodenectomy

Study

Anxiety and depression in patients with cancer

Disease

API-CAT

Study

Appendiceal neoplasm

Disease

AQCS-Assisted Colonoscopy

Study

AQUILA

Study

ARASENS

Study

ARCADIA (post-hoc analysis)

Study

ARES (aspirin BID vs. aspirin OD)

Study

ARES (aspirin TID vs. aspirin OD)

Study

ASC4FIRST

Study

ASCEMBL

Study

Astrocytoma and oligodendroglioma

Disease

Atezolizumab

Drug

Atezolizumab / hyaluronidase

Drug

ATLAS (tamoxifen)

Study

Atrophic gastritis

Disease

ATTR-ACT

Study

ATTRibute-CM

Study

Autoimmune hemolytic anemia

Disease

AVERT (subgroup analysis)

Study

Axillary lymphadenopathy

Finding

AZA-001

Study